SENP3 and neoplasm: The secretome testing on the cell supernatant of the SENP3 deletion group indicated down-regulation of the anti-tumor factors (CCL5 and IL-β) and up-regulation of tumor-promoting factors (IL-10 and TGF-β) (Fig. 3E).